Skip to main content

Table 2 BAL Fluid Cell Characteristics

From: Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis

  IPF (n = 19) Sar (n = 6) CVD-IP (n = 8) HV (n = 6)
Total cells
(105/ml)
6.2 ± 0.8
(1.9-14.8)
4.9 ± 0.3
(4.0-6.0)
11.2 ± 3.1*
(1.1-27.9)
2.7 ± 0.5
(0.6-4.0)
Macrophage
(%)
78.0 ± 2.6
(60.2-97.0)
62.9 ± 10.8* (29.5-95.0) 44.0 ± 9.9 (5.5-74.5) 95.6 ± 0.3§$
(94.7-96.6)
Lymphocyte
(%)
11.3 ± 2.1
(0-27.4)
34.6 ± 10.5*
(5.0-68.5)
33.8 ± 8.7*
(12.0-87.5)
3.1 ± 0.2
(2.6-4.0)
Neutrophil
(%)
6.1 ± 1.4
(1.0-23.0)
1.7 ± 0.8
(0-4.0)
18.4 ± 8.6|#£
(0-65.5)
1.1 ± 0.1
(0.7-1.6)
Eosinophil
(%)
4.4 ± 1.1∫#
(0-14.5)
0.5 ± 0.3
(0-1.9)
1.7 ± 0.9
(0-7.5)
0.2 ± 0.2
(0-0.9)
CD4/CD8 3.1 ± 0.6
(0.2-9.6)
11.2 ± 4.0
(2.4-29.3)
1.8 ± 0.5
(0.4-3.9)
N.D.
  1. IPF, idiopathic pulmonary fibrosis; Sar, sarcoidosis; CVD-IP, collagen vascular disease with interstitial pneumonia; HV, healthy volunteers; N.D., not determined
  2. All data were shown as mean ± SEM.
  3. "p < 0.0001 v.s. HV, *p < 0.005 v.s. HV, p < 0.05 v.s. HV
  4. p < 0.0005 v.s. CVD-IP, &p < 0.005 v.s. CVD-IP
  5. $p < 0.005 v.s. Sar, #p < 0.05 v.s. Sar
  6. §p < 0.0001 v.s. IPF, ¥p < 0.001 v.s. IPF, p < 0.005 v.s. IPF, £p < 0.05 v.s. IPF